Advanced in Cardiomyopathy Due to Anthracyclines

Pietro Ameri

Genoa, IT 
Advanced in Cardiomyopathy Due to Anthracyclines
Genoa, IT 
OverviewLocationsClinical Research

Overview

Pietro Ameri practices in Genoa, Italy. Mr. Ameri is rated as an Advanced expert by MediFind in the treatment of Cardiomyopathy Due to Anthracyclines. His top areas of expertise are Heart Failure, Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Hypertension, and Heart Transplant.

His clinical research consists of co-authoring 209 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Cardiomyopathy Due to Anthracyclines.

Gender
Male

Locations

Genoa, 16132, Italy
Other Locations
Foggia, Italy
San Martino Di Venezze, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: Rodatristat Ethyl
Study Phase: Phase 2
View 1 Less Clinical Trial

209 Total Publications

ESC cardio-oncology conference hits the ground running.
ESC cardio-oncology conference hits the ground running.
Journal: European heart journal
Published: September 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ameri's expertise for a condition
ConditionClose
    View All 34 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile